Sponsor:
Joseph Tuscano
Code:
NCT04587687
Conditions
Recurrent Follicular Lymphoma
Refractory Follicular Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Bendamustine Hydrochloride
Brentuximab Vedotin
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-23. This information was provided to ClinicalTrials.gov by Joseph Tuscano on 2025-04-24.